Komori
Recomm (3323) · TargetRestated

Consolidated net sales of ¥22 billion and consolidated operating income of ¥2 billion for the fiscal year ended September 2022

First written in FY2020. 4 of 6 entries say "Restated". Latest entry: FY2023-Q3.

6entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2020ReframedFY2021RestatedFY2022 – FY2023-Q32020: 12021: 120212022: 120222023: 32023
Same theme, other companies
Setting and achieving performance targets under the medium-term management planA theme 791 companies write about · 75 as a headwind · 1062 as a tailwind

The whole theme swung hardest in 2021: 17 of 77 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 133 companies compared. The sentences above are computed from all 133.Comparing 200 of the theme's 1182 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2023-Q3RestatedAnnual report

    「In this management environment, our group has adopted its Global Specialized Trading Company concept to achieve the medium-term management plan ending in the fiscal year ending September 2024, and is pursuing 3 priority initiatives: ① expanding the overseas solutions business, ② promoting products related to DX, decarbonization and infectious disease control, and ③ expanding recurring revenue.」

    The company has reconfirmed its medium-term management plan, whose final year is the fiscal year ending September 2024, and its priority initiatives centred on the overseas solutions business, DX, decarbonisation and products addressing infectious diseases, and recurring revenue.
  2. FY2023-Q2RestatedAnnual report

    「In this management environment, our group has adopted its Global Specialized Trading Company concept to achieve the medium-term management plan ending in the fiscal year ending September 2024, and is pursuing 3 priority initiatives: ① expanding the overseas solutions business, ② promoting products related to DX, decarbonization and infectious disease control, and ③ expanding recurring revenue.」

    The company has reconfirmed its priority initiatives for achieving the medium-term management plan, whose final year is the fiscal year ending September 2024, and its vision of becoming a global specialised trading company.
  3. FY2023-Q1RestatedAnnual report

    「In this environment, our group has adopted its Global Specialized Trading Company concept to achieve the medium-term management plan ending in the fiscal year ending September 2024, and is pursuing 3 priority initiatives: ① expanding the overseas solutions business, ② promoting products related to DX, decarbonization and infectious disease control, and ③ expanding recurring revenue.」

    The company continues its priority initiatives for achieving the medium-term management plan, whose final year is the fiscal year ending September 2024, and its vision of becoming a global specialised trading company.
  4. FY2022RestatedAnnual report

    「During the current fiscal year, the company formulated a medium-term management plan for October 2021 to September 2024 that positions the overseas business as a growth driver, with targets of an annual average sales growth rate of at least 30%, an overseas solutions business contribution of at least 50% of operating profit, and a market capitalisation of ¥30.0 billion. In addition, for the fiscal year ending September 2024, the final year of the medium-term management plan, the company is targeting consolidated revenue of ¥15.0 billion and consolidated operating profit of ¥1.5 billion and will pursue business expansion.」

    The company has reiterated the numerical targets of its medium-term management plan, whose final year is the fiscal year ending September 2024, and the positioning of the overseas business as a growth driver.
  5. FY2021ReframedAnnual report

    「During the current fiscal year, we formulated a medium-term management plan for October 2021 to September 2024, positioning the overseas business as a growth driver. Its targets are annual revenue growth of at least 30%, an overseas Solutions Business share of at least 50% of operating profit, and a market capitalization of ¥30 billion. For the fiscal year ending September 2024, the final year of the plan, we are targeting consolidated revenue of ¥15 billion and consolidated operating profit of ¥1.5 billion and will seek to expand the business.」

    The company revised its targets from the previous plan, which called for consolidated net sales of ¥22.0 billion and consolidated operating profit of ¥2.0 billion for the fiscal year ending September 2022, to a new medium-term management plan calling for revenue of ¥15.0 billion and operating profit of ¥1.5 billion for the fiscal year ending September 2024.
  6. FY2020First statedAnnual report

    「The company will seek to expand sales in order to achieve consolidated net sales of ¥22.0 billion and consolidated operating profit of ¥2.0 billion for the fiscal year ending September 2022, the final year of its medium-term management plan.」

    The company disclosed for the first time the numerical targets of consolidated net sales of ¥22.0 billion and consolidated operating profit of ¥2.0 billion for the fiscal year ending September 2022 under its medium-term management plan, which positions the overseas business as a growth driver.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Recomm yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Consolidated net sales of ¥22 billion and consolidated operating income of ¥2 billion for the fiscal year ended September 2022 | RECOMM CO.,LTD. (3323) | Komori